Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer

Annals of Clinical and Laboratory Science

Volumn 38, Issue 2, 2008, Pages 113-119

  Zhang, Dianliang ^a   Zhou, Yanbin ^a   Wu, Liqun ^a   Wang, Shuchun ^a   Zheng, Hongmei ^a   Yu, Baojun ^b   Li, Jieshou ^b  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Cachexia; Cytokines; IL 6 gene polymorphism; Pancreatic cancer

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER SURVIVAL; CHINESE; COMMON BILE DUCT OBSTRUCTION; DUODENUM OBSTRUCTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CACHEXIA; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES;

EID: 43449137883     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Rossi Fanelli F. Prevention and treatment of cancer cachexia: New insights into an old problem, Eur J Cancer 2006;42:31-41.
2. Tisdale MJ. Protein loss in cancer cachexia. Science 2000;289:2293-2294.
3. Barton BE. IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation. Immunol Res 2001;23:41-58.
4. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000;16:1009-1012.
5. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 1999;59:4493-4501.
6. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002;2:862-871.
7. Argiles JM, Busquets S, Lopez-Soriano FJ. Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care 2003;6:401-406.
8. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J Clin Invest 1992;89:1681-1684.
9. Matthew D, Barber JA, Ross KCH, Fearon MD. Disordered metabolic response with cancer and its management. World J Surg 2000;24:681-689.
10. Scott HR, McMillan DC, Crilly A, McArdle CS, Milroy R. The relationship between weight loss and interleukin 6 in non small-cell lung cancer. Br J Cancer 1996;73:1560-1562.
11. Okada S, Okusaka T, Ishii H, Kyogoku A, Yoshimori M, Kajimura N, Yamaguchi K, Kakizoe T. Elevated serum interleukin-6 levels in patients with pancreatic cancer. Jpn J Clin Oncol 1998;28:12-15.
12. Martignoni ME, Kunze P, Hildebrandt W, Kunzli B, Berberat P, Giese T, Kloters O, Hammer J, Buchler MW, Giese NA, Friess H. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res 2005;11:5802-5808.
13. Pascual M, Nieto A, Mataran L, Balsa A, Pascual-Salcedo D, Martin J . IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000;1:3338-3340.
14. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart WJ . Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. Clin Endocrinol Metab 2000;85:1331-1333.
15. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001;46:267-272.
16. Baracos VE. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition 2000;16:1015-1018.
17. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002;94:2511-2516.
18. Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, Yamaoka Y Interleukin-6 Genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003;8:142-148.
19. Komatsu Y, Tai H, Galicia JC, Shimada Y, Endo M, Akazawa K, Yamazaki K, Yoshie H. Interleukin-6 (IL-6) -373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level. Tissue Antigens 2005;65:110-114.
20. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001;46: 267-272.
21. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049-1057.
22. Townsend JR. Malignant pancreatic tumors. In: Sabiston's Textbook of Surgery, 17th ed (Townsend CM, Beauchamp RD, Evers BM, Mattox KL, Eds), Saunders, Philadelphia, 2004; pp 1669.
23. Kitawaki J, Kiyomizu M, Obayashi H, Ohta M, Ishihara H, Hasegawa G, Nakamura N, Yoshikawa T, Honjo H.. Synergistic effect of interleukin-6 promoter (IL6) 634C/G and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women. Am J Reprod Immunol 2006;56:267-274.
24. Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M.. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999;1:115-119.
25. Feng D, Ishibashi H, Yamamoto S, Hosoi T, Orimo H, Machida T, Koshihara Y. Association between bone loss and promoter polymorphism in the IL-6 gene in elderly Japanese women with hip fracture. J Bone Miner Metab 2003;21:225-228.
26. Kotier DP. Cachexia. Ann Intern Med 2000;133:622-634.
27. Ye W, Huang DS, Liu SL, Ding Y, Peng Y, Hu BS, Lv HR. Association of single nucleotide polymorphism in interleukin 6 gene with lumbar intervebral disc disease. Chin J Path 1996;22:647-674.
28. Chang YH, Huang CN, Shiau MY. The C-174G promoter polymorphism of the interleukin-6 (IL-6) gene that affects insulin sensitivity in Caucasians is not involved in the pathogenesis of Taiwanese type 2 diabetes mellitus. Eur Cytokine Netw 2004;15:117-119.
29. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene -174g>c and -572 g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-1463.
30. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 2002;114:436-439.